Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001854270-24-000116
Filing Date
2024-11-14
Accepted
2024-11-14 16:51:11
Documents
84
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q snti-20240930.htm   iXBRL 10-Q 1998060
2 EX-10.2 a20240930ex102sublease-bkp.htm EX-10.2 193241
3 EX-10.3 a20240930ex103-storagelice.htm EX-10.3 33320
4 EX-31.1 a2024093010qex311.htm EX-31.1 11474
5 EX-31.2 a2024093010qex312.htm EX-31.2 11455
6 EX-32.1 a2024093010qex321.htm EX-32.1 5599
7 EX-32.2 a2024093010qex322.htm EX-32.2 5588
  Complete submission text file 0001854270-24-000116.txt   8744141

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20240930.xsd EX-101.SCH 58738
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snti-20240930_cal.xml EX-101.CAL 83658
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snti-20240930_def.xml EX-101.DEF 416166
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20240930_lab.xml EX-101.LAB 701038
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20240930_pre.xml EX-101.PRE 556983
87 EXTRACTED XBRL INSTANCE DOCUMENT snti-20240930_htm.xml XML 901634
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40440 | Film No.: 241463750
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)